G.C. Starling
Bristol-Myers Squibb Pharmaceutical Research Institute
Seattle
WA 98121
USA
Name/email consistency: high
- Analysis of the ligand binding site in Fas (CD95) by site-directed mutagenesis and comparison with TNFR and CD40. Starling, G.C., Kiener, P.A., Aruffo, A., Bajorath, J. Biochemistry (1998)
- Characterization of mouse CD6 with novel monoclonal antibodies which enhance the allogeneic mixed leukocyte reaction. Starling, G.C., Whitney, G.S., Siadak, A.W., Llewellyn, M.B., Bowen, M.A., Farr, A.G., Aruffo, A.A. Eur. J. Immunol. (1996)